Form 4 LIFECORE BIOMEDICAL, For: Dec 06 Filed by: Lake Ryan David
Lifecore Biomedical, Inc. (LFCR)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
LFCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LFCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LFCR alerts
High impacting Lifecore Biomedical, Inc. news events
Weekly update
A roundup of the hottest topics
LFCR
News
- Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025 [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025GlobeNewswire
- Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment [Yahoo! Finance]Yahoo! Finance
- Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder TreatmentGlobeNewswire
- Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the InvestigationAccesswire
LFCR
Sec Filings
- 12/10/24 - Form 4
- 11/12/24 - Form SC
- 10/29/24 - Form 4
- LFCR's page on the SEC website